Sildenafil increases diclofenac antinociception in the formalin test
Authors:
- 1 April 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 418 (3) , 195-200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:Trends in Endocrinology & Metabolism, 1999
- Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 1996
- Sildenafil, a novel effective oral therapy for male erectile dysfunctionBritish Journal of Urology, 1996
- Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolacEuropean Journal of Pharmacology, 1995
- Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitizationEuropean Journal of Pharmacology, 1994
- Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathwayEuropean Journal of Pharmacology, 1992
- The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide releaseEuropean Journal of Pharmacology, 1991
- Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathwayEuropean Journal of Pharmacology, 1990
- Diclofenac SodiumDrugs, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983